Nanodiagnosis and nanotreatment of cardiovascular diseases: An overview
Cardiovascular diseases (CVDs) are the world's leading cause of mortality and represent a
large contributor to the costs of medical care. Although tremendous progress has been …
large contributor to the costs of medical care. Although tremendous progress has been …
Cardiovascular nanomedicine: the route ahead
Heart failure, coronary cardiac disease, myocardial infarction and inflammatory heart
disease, along with other cardiovascular diseases (CVDs), account for the widest health …
disease, along with other cardiovascular diseases (CVDs), account for the widest health …
Nanomedicines for endothelial disorders
The endothelium lines the internal surfaces of blood and lymphatic vessels and has a critical
role in maintaining homeostasis. Endothelial dysfunction is involved in the pathology of …
role in maintaining homeostasis. Endothelial dysfunction is involved in the pathology of …
Nanotechnology in diagnosis and treatment of coronary artery disease
Nanotechnology could provide a new complementary approach to treat coronary artery
disease (CAD) which is now one of the biggest killers in the Western world. The course of …
disease (CAD) which is now one of the biggest killers in the Western world. The course of …
Nanoparticle-mediated drug delivery system for cardiovascular disease
T Matoba, K Egashira - International heart journal, 2014 - jstage.jst.go.jp
Administration of drugs and other therapeutic agents has been the central strategy of
contemporary medicine for cardiovascular disease. The use of a drug delivery system (DDS) …
contemporary medicine for cardiovascular disease. The use of a drug delivery system (DDS) …
Current advances in the use of nanophytomedicine therapies for human cardiovascular diseases
M Hesari, P Mohammadi, F Khademi… - International journal …, 2021 - Taylor & Francis
Considering the high prevalence of cardiovascular diseases (CVDs), the primary cause of
death during the last several decades, it is necessary to develop proper strategies for the …
death during the last several decades, it is necessary to develop proper strategies for the …
[HTML][HTML] Cardioprotective effects of nanoparticles in cardiovascular diseases: A state of the art review.
It has been reported that death related to cardiovascular disease has increased up to 12.5%
just in the past decade alone with various factors playing a role. In 2015 alone it has been …
just in the past decade alone with various factors playing a role. In 2015 alone it has been …
The upcoming field of theranostic nanomedicine: an overview
P Prabhu, V Patravale - Journal of Biomedical Nanotechnology, 2012 - ingentaconnect.com
Nanocarriers have drastically changed the face of health care by making a mark in diverse
arenas of diagnosis, drug delivery, and gene delivery to name a few. The recent feat in …
arenas of diagnosis, drug delivery, and gene delivery to name a few. The recent feat in …
[HTML][HTML] Current research trends of nanomedicines
Owing to the inherent shortcomings of traditional therapeutic drugs in terms of inadequate
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
therapeutic efficacy and toxicity in clinical treatment, nanomedicine designs have received …
Nanoscale technologies for prevention and treatment of heart failure: challenges and opportunities
MJ Hajipour, M Mehrani, SH Abbasi, A Amin… - Chemical …, 2019 - ACS Publications
The adult myocardium has a limited regenerative capacity following heart injury, and the lost
cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical …
cells are primarily replaced by fibrotic scar tissue. Suboptimal efficiency of current clinical …